Stock Taper
Progyny, Inc. offers fertility and family building benefits, including personalized support, pharmacy services, and surrogacy/adoption reimbursement, to U.S. employers.

A benefits management platform for employers offering employees access to fertility, family building, and women's health services through 'Smart Cycle' coverage, specialist networks, and personalized concierge support.
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | Fertility benefit services revenue | $201.95M | $208.63M ▲ | $209.43M ▲ | $230.21M ▲ |
![]() | Pharmacy benefit services revenue | $111.4M | $109.77M ▼ | $119.07M ▲ | $120.3M ▲ |
Overall rating: A-
| PEER | PRICE | |
|---|---|---|
TXG | $65.12 | COMPARE |
UFPT | $309.13 | COMPARE |
OMCL | $35.58 | COMPARE |
ALVO | $4.43 | COMPARE |
SDGR | $19.71 | COMPARE |
OMDA | $23.89 | COMPARE |
GDRX | $3.45 | COMPARE |
TDOC | $6.39 | COMPARE |